 SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores
SMC Global Securities Ltd Q2 FY2025-26 consolidated net profit declines to Rs. 20.65 crores Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores
Rajoo Engineers Ltd Q2FY26 consolidated profit at Rs. 14.18 crores Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores
Inventurus Knowledge Solutions Ltd consolidated Q2 FY2025-26 PAT climbs to Rs. 180.71 crores IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores
IFB Industries Ltd consolidated PAT for Q2FY26 jumps to Rs. 50.79 crores Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores
Share India Securities Ltd consolidated Q2 FY26 net profit at Rs. 92.91 crores 
              By Mr Vishal Wagh, Research Head
"Corona Virus's impact dragged the global market in the red zone. As news is giving clues, conditions in China are deteriorating further with the passing time. This is most probably a strong reason to see a rally in pharmaceutical companies. At the same time, Dr Reddy has come with a good set of numbers. Banking stocks remained under pressure and profit booking has seen in Midcap counters. Nifty broken 50 days simple moving average and closed just below it. Moving forward 12,088 and 12,048 levels will play last hope for bulls. Market breadth remained in favour of bear for every four winning stocks, there were five losers. India VIX gained by 11.40%. Major losses have seen in the Nifty Metal and Nifty PSU Banks index whereas, pharma was only winning index in all sectoral indices. INR lost fourteen paise against USD till the time. Due to the natural hedging nature of yellow metal, it is managed to hold in green so far. Volatility has increased into the market so, it is suggested to stay away from the market for the time being."